$DYCQ
DT Cloud Acquisition Corp

2024 Q2 Form 10-Q Financial Statement

#000149315224018178 Filed on May 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $78.47K $302.4K $82.01K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $78.47K $302.4K $82.01K
YoY Change 30433.07%
Operating Profit
YoY Change
Interest Expense $907.3K $346.3K
YoY Change
% of Operating Profit
Other Income/Expense, Net $907.3K $346.3K
YoY Change
Pretax Income $828.9K $43.88K -$82.01K
YoY Change
Income Tax
% Of Pretax Income
Net Earnings $828.9K $43.88K -$82.01K
YoY Change -322615.95%
Net Earnings / Revenue
Basic Earnings Per Share $0.09 $0.01
Diluted Earnings Per Share $0.09 $0.01 -$0.05
COMMON SHARES
Basic Shares Outstanding 8.963M shares 1.862M shares
Diluted Shares Outstanding 2.063M shares 1.862M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $314.4K $339.8K $494.8K
YoY Change
Cash & Equivalents $314.4K $339.8K $494.8K
Short-Term Investments
Other Short-Term Assets $53.06K $74.17K $8.450K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $367.5K $414.0K $503.3K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $70.60M $69.69M
YoY Change
Other Assets $0.00 $0.00 $85.00K
YoY Change
Total Long-Term Assets $70.60M $69.69M $85.00K
YoY Change -10.53%
TOTAL ASSETS
Total Short-Term Assets $367.5K $414.0K $503.3K
Total Long-Term Assets $70.60M $69.69M $85.00K
Total Assets $70.97M $70.11M $588.3K
YoY Change 519.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $103.0K $101.1K $24.25K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $217.6K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $143.0K $111.1K $731.9K
YoY Change 383.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.725M $1.725M
YoY Change
Total Long-Term Liabilities $1.725M $1.725M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $143.0K $111.1K $731.9K
Total Long-Term Liabilities $1.725M $1.725M $0.00
Total Liabilities $1.868M $1.836M $731.9K
YoY Change 383.63%
SHAREHOLDERS EQUITY
Retained Earnings -$1.501M -$1.422M -$168.6K
YoY Change 107.31%
Common Stock $206.00 $206.00 $173.00
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.501M -$1.422M -$143.6K
YoY Change
Total Liabilities & Shareholders Equity $70.97M $70.11M $588.3K
YoY Change 519.23%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $828.9K $43.88K -$82.01K
YoY Change -322615.95%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$25.43K -$498.9K $4.820K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$69.35M
YoY Change
Cash From Investing Activities $0.00 -$69.35M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 $69.69M 490.0K
YoY Change
NET CHANGE
Cash From Operating Activities -25.43K -$498.9K 4.820K
Cash From Investing Activities 0.000 -$69.35M
Cash From Financing Activities 0.000 $69.69M 490.0K
Net Change In Cash -25.43K -$155.0K 494.8K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$25.43K -$498.9K $4.820K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Cash
Cash
usd
CY2024Q1 us-gaap Escrow Deposit
EscrowDeposit
usd
CY2024Q1 us-gaap Escrow Deposit
EscrowDeposit
usd
CY2024Q1 us-gaap Deferred Costs
DeferredCosts
usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
usd
CY2023Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
usd
CY2023Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
CY2024Q1 DTCA Stock Issued During Period Value Representative Share
StockIssuedDuringPeriodValueRepresentativeShare
usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
CY2023Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
CY2023Q1 us-gaap Payments For Proceeds From Other Deposits
PaymentsForProceedsFromOtherDeposits
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q1 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
usd
CY2023Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
CY2023Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023Q1 us-gaap Escrow Deposit
EscrowDeposit
usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2023Q1 DTCA Issuance Of Representative Share
IssuanceOfRepresentativeShare
usd
CY2023Q1 DTCA Initial Classification Of Common Stock Subject To Possible Redemption
InitialClassificationOfCommonStockSubjectToPossibleRedemption
usd
CY2023Q1 DTCA Allocation Of Offering Costs To Common Stock Subject To Possible Redemption
AllocationOfOfferingCostsToCommonStockSubjectToPossibleRedemption
usd
CY2023Q1 DTCA Accretion Of Carrying Value To Redemption Value
AccretionOfCarryingValueToRedemptionValue
usd
CY2023Q1 DTCA Subsequent Remeasurement Of Common Stock Subject To Redemptions
SubsequentRemeasurementOfCommonStockSubjectToRedemptions
usd
CY2023Q1 DTCA Accrued Underwriting Compensation
AccruedUnderwritingCompensation
usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
usd
CY2024Q1 us-gaap Cash
Cash
339837 usd
CY2023Q4 us-gaap Escrow Deposit
EscrowDeposit
425000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
74168 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
414005 usd
CY2023Q4 us-gaap Deferred Costs
DeferredCosts
85000 usd
CY2024Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
69691250 usd
CY2024Q1 us-gaap Assets
Assets
70105255 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
101083 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
111083 usd
CY2024Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
1725000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
1836083 usd
CY2024Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
6900000 shares
CY2024Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
6900000 shares
CY2023Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2024Q1 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.10
CY2023Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
0
CY2024Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
69691250 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2063000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2063000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1725000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1725000 shares
CY2024Q1 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
6900000 shares
CY2023Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
0 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
206 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24827 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1422284 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1422078 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
70105255 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
302382 usd
CY2024Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
346250 usd
CY2024Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
7 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
346257 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
43875 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1862429 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1862429 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1500000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1500000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-143597 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
66023894 usd
CY2024Q1 DTCA Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
2345000 usd
CY2024Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-68014286 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
2933590 usd
CY2024Q1 DTCA Adjustments To Additional Paid In Capital Redemption Value
AdjustmentsToAdditionalPaidInCapitalRedemptionValue
-4264304 usd
CY2024Q1 DTCA Subsequent Remeasurement Of Common Stock Subject To Redemption
SubsequentRemeasurementOfCommonStockSubjectToRedemption
-346250 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
43875 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1422078 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-56326 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-56326 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-56326 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-56326 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
43875 usd
CY2024Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
346250 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
65722 usd
CY2024Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-207614 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
76836 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-498875 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Deposits
PaymentsForProceedsFromOtherDeposits
69345000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-69345000 usd
CY2024Q1 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-490000 usd
CY2024Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
67833894 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
2345000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
69688894 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-154981 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
494818 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
339837 usd
CY2024Q1 us-gaap Cash
Cash
339837 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
339837 usd
CY2024Q1 DTCA Issuance Of Representative Share
IssuanceOfRepresentativeShare
10 usd
CY2024Q1 DTCA Initial Classification Of Common Stock Subject To Possible Redemption
InitialClassificationOfCommonStockSubjectToPossibleRedemption
68014286 usd
CY2024Q1 DTCA Allocation Of Offering Costs To Common Stock Subject To Possible Redemption
AllocationOfOfferingCostsToCommonStockSubjectToPossibleRedemption
2933590 usd
CY2024Q1 DTCA Accretion Of Carrying Value To Redemption Value
AccretionOfCarryingValueToRedemptionValue
4264304 usd
CY2024Q1 DTCA Subsequent Remeasurement Of Common Stock Subject To Redemptions
SubsequentRemeasurementOfCommonStockSubjectToRedemptions
346250 usd
CY2024Q1 DTCA Accrued Underwriting Compensation
AccruedUnderwritingCompensation
1725000 usd
CY2024Q1 DTCA Percent Of Obligation To Redeem Public Shares
PercentOfObligationToRedeemPublicShares
1 pure
CY2024Q1 DTCA Percent Of Obligation To Redeem Public Shares
PercentOfObligationToRedeemPublicShares
1 pure
CY2024Q1 us-gaap Deposits
Deposits
207000 usd
CY2024Q1 DTCA Percent Of Obligation To Redeem Public Shares
PercentOfObligationToRedeemPublicShares
1 pure
CY2024Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.05
CY2024Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.05
CY2024Q1 DTCA Percent Of Obligation To Redeem Public Shares
PercentOfObligationToRedeemPublicShares
1 pure
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
490000 usd
CY2024Q1 DTCA Unpaid Services Fee
UnpaidServicesFee
10000 usd
CY2023Q4 DTCA Unpaid Services Fee
UnpaidServicesFee
0 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_zDeYz6iGUDug" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">● <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_864_zuEIyrNT5HX5">Use of estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of unaudited financial statement in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DT CLOUD ACQUISITION CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO UNAUDITED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p>
CY2024Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
6900000 shares
CY2024Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
6900000 shares
CY2023Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
43875 usd
CY2024Q1 DTCA Incurred Fees
IncurredFees
10000 usd
CY2023Q1 DTCA Incurred Fees
IncurredFees
0 usd
CY2024Q1 DTCA Working Capital Loans
WorkingCapitalLoans
0 usd
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zG7bhgBeU8sa" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86A_zWMXKO0cCoed">Concentration of credit risk</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1725000 shares
CY2022Q3 DTCA Percentage Of Issued And Outstanding Shares After Initial Public Offering Collectively Held By Initial Stockholders
PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders
0.20 pure
CY2022Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000 usd
CY2024Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
10000 usd
CY2023Q4 DTCA Working Capital Loans
WorkingCapitalLoans
0 usd
CY2024Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
6900000 shares
CY2024Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
6900000 shares
CY2023Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2024Q1 us-gaap Common Stock Voting Rights
CommonStockVotingRights
Each holder of a right will receive one-seventh (1/7) ordinary share upon consummation of a Business Combination, even if the holder of such right redeemed all shares held by it in connection with a Business Combination. No fractional shares will be issued upon exchange of the rights.

Files In Submission

Name View Source Status
0001493152-24-018178-index-headers.html Edgar Link pending
0001493152-24-018178-index.html Edgar Link pending
0001493152-24-018178.txt Edgar Link pending
0001493152-24-018178-xbrl.zip Edgar Link pending
dtca-20240331.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
dtca-20240331_lab.xml Edgar Link unprocessable
dtca-20240331_pre.xml Edgar Link unprocessable
dtca-20240331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
dtca-20240331_def.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending